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Abstract
Brill-Zinsser disease, the relapsing form of epidemic typhus, typically occurs in a susceptible host years or decades after the
primary infection; however, the mechanisms of reactivation and the cellular reservoir during latency are poorly understood.
Herein we describe a murine model for Brill-Zinsser disease, and use PCR and cell culture to show transient rickettsemia in
mice treated with dexamethasone .3 months after clinical recovery from the primary infection. Treatment of similarly
infected mice with cyclosporine failed to produce recrudescent bacteremia. Therapy with doxycycline for the primary
infection prevented recrudescent bacteremia in most of these mice following treatment with dexamethasone. Rickettsia
prowazekii (the etiologic agent of epidemic typhus) was detected by PCR, cell culture, and immunostaining methods in
murine adipose tissue, but not in liver, spleen, lung, or central nervous system tissues of mice 4 months after recovery from
the primary infection. The lungs of dexamethasone-treated mice showed impaired expression of b-defensin transcripts that
may be involved in the pathogenesis of pulmonary lesions. In vitro, R. prowazekii rickettsiae infected and replicated in the
murine adipocyte cell line 3T3-L1. Collectively these data suggest a role for adipose tissue as a potential reservoir for
dormant infections with R. prowazekii.
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Introduction
Epidemic, or louse-borne typhus, caused by Rickettsia prowazekii,
is a potentially fatal disease that typically occurs as large, explosive
outbreaks associated with war, famine, and overcrowding during
periods of civil turmoil [1–3]. Until recently; epidemic typhus was
considered a disease of the past; however it re-emerged
dramatically in 1997 in Burundi where it affected an estimated
100,000 refugees of the Rwanda civil war [4–6]. The disease also
has occurred recently as smaller outbreaks, in Russia in 1997 [7]
Peru in 1998 [8], and as isolated sporadic cases in Algeria [9,10]
the United States [11] and Europe [12].
R. prowazekii rickettsiae can remain dormant for years or even
decades in patients who recover from the primary infection [13].
In certain individuals, stress or waning immunity are likely to
reactivate this persistent infection, and cause a recrudescent form
of typhus known as Brill-Zinsser disease [14,15]. Cases of Brill-
Zinsser disease have been reported in the United States [16–18],
Canada [19] and Europe [20]. Brill noted that, ‘‘the causative
agent of typhus, once acquired, remains latent for many years in
an indeterminable number of individuals and may become active
in a fraction of these under circumstances of fading immunity’’
[21]; however, the precise pathophysiologic cues that reactivate
infection remain unknown. Brill-Zinsser disease is considered a
milder illness than classical epidemic typhus, and the case-fatality
rate of non-treated recrudescent disease is approximately 1.2%–
2.5% [22,23]; nonetheless, many patients with Brill Zinsser disease
are moderately to severely ill [14,22,23].
The anatomic and cellular locations of dormant R. prowazekii
rickettsiae have remained a mystery since the first descriptions of
recrudescent typhus by Brill nearly 100 years ago [14,22]. By using
a recently developed murine model of epidemic typhus [24], we
describe an experimental model of recrudescent typhus, and
identify adipose tissue as a site from which dormant R. prowazekii
rickettsiae can be reactivated.
Results
Effect of Dexamethasone and Cyclosporine on R.
prowazekii Reactivation in Mice
Rickettsemias of 28 BALB/c mice infected with R. prowazekii
were determined by quantative real-time PCR (qPCR). The
highest levels were observed 3 to 6 days post-infection (pi),
decreased by day 9, and were non-detectable at day 30 pi. One
month after no rickettsial DNA could be detected in the blood of
previously infected mice (60 days post-inoculation), groups of mice
were given either dexamethasone for 30 days, cyclosporine for 20
days, or PBS for 20 days. The immunosuppressing effects of these
regimens were assessed by measuring IFN-c release by mouse
splenocytes harvested at the end of the immunosuppressive
treatment and stimulated in vitro with heat-inactivated R.
prowazekii. Levels of IFN-c released from splenocytes of infected
mice treated with dexamethasone or cyclosporine were signifi-
cantly decreased compared to the levels in infected mice that
received sham immunosuppression (table 1).
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range=12 to 118 copies/mL blood) was detected by using qPCR
in 7 (88%) of the 8 dexamethasone-treated mice 3 days after the
completion of treatment, and disappeared by 8 days (table 2). The
amount of rickettsial DNA varied by tissue type, and ranged from
14 to 147 copies/mg tissue in livers, 234 to 317 copies/mg tissue in
lungs, 420 to 705 copies/mg tissue in brains, and from (24 to 1750
copies/mg tissue in spleens) (table 2). DNA of R. prowazekii
remained detectable in several of these tissues 8 days following the
completion of dexamethasone treatment (1/3 mice in liver and
spleen and 3/3 mice in lung and brain). DNA of R. prowazekii was
not detected by qPCR in the blood of any cyclosporine-treated or
sham-immunosuppressed mouse.
R. prowazekii rickettsiae were isolated in L929 cells from blood
and tissues of dexamethasone-treated mice. Rickettsiae were
identified in Gimenez and immunofluoresence-stained cell culture
inoculated with blood or triturates of spleen, liver, lungs, or brain
harvested from 4 mice at 3 days following the completion of
therapy. Rickettsiae could be seen in L929 cells within 7 to 14 days
following inoculation with blood or tissue. No R. prowazekii
rickettsiae were isolated in cell cultures inoculated with blood or
tissue samples harvested from mice 8 days following completion of
dexamethasone treatment.
The titers of anti-R. prowazekii IgG antibodies in the dexameth-
asone-treated mice (geometric mean titer=5570, range=3200–
12800) were significantly greater than the titers observed in mice
treated with cyclosporine (geometric mean titer=696,
range=400–1600) or sham-immunosuppressed mice (geometric
mean titer=696, range=400–1600). No post-treatment IgM
antibodies were detected in dexamethasone-treated mice.
Effect of Doxycycline on R. prowazekii Reactivation
Antirickettsial therapy (i.e., doxycycline) administered to mice at
the time of the primary infection diminished the occurrence of
detectable rickettsiae in blood and tissues following treatment with
dexamethasone. A transient rickettsemia was identified in only 1 of
6 (17%) doxycycline-treated mice following dexamethasone
treatment, significantly less than the frequency of rickettsemia in
dexamethasone-treated mice receiving no doxycycline (88%). The
blood of the mouse treated with doxycycline contained only 24
DNA copies/mL blood significantly lower than the number of
copies observed in dexamethasone-treated mice receiving no
doxycycline. No rickettsial DNA was detected in the livers, brains
or spleens of dexamethasone-treated mice that received doxycy-
cline during the primary infection.
b-defensin Expression and Histopathology of Lungs of
Mice with Relapsing Rickettsemia
The lungs of dexamethasone-treated mice showed impaired
expression of b-defensin transcripts (ratio of expression levels of
28.2563.7). Multifocal intraalveolar hemorrhages, and interstitial
lymphohistiocytic infiltrates were identified in the lungs of
mice sacrificed following dexamethasone-reactivated infection
(Figure 1A). In general, these lesions were similar to, but less
extensive (Figure 1B) than the pulmonary lesions that developed in
mice following primary infection with R. prowazekii [24]; however,
Table 1. Levels of interferon (IFN)-c secreted by murine
splenocytes following treatments with dexamethasone or
cyclosporine.
IFN-c content (pg/ml)
Treatment Stimulated Not stimulated
PBS control 1146664 355634
Cyclosporine 117631 81618
Dexamethasone 72612 2065
doi:10.1371/journal.pone.0008547.t001
Table 2. Mean DNA copies of Rickettsia prowazekii in
peripheral blood and various tissues sampled from
doxycycline-treated or non-treated mice with
dexamethasone-reactivated typhus infections.
Mean DNA copies/mL blood or mg tissue (no. mice
positive/no. tested)
Sample
Primary infection treated
with doxycycline Without doxycycline
Blood 24 (1/6) 73 (7/8)
Liver ND 80 (2/5)
Spleen ND 910 (2/5)
Lungs 338 (1/6) 276 (2/5)
Brain ND 374 (2/5)
ND: no DNA detected.
doi:10.1371/journal.pone.0008547.t002
Figure 1. Histopathology of lung lesions in BALB/c mice.
Pulmonary parenchyma from mice with reactivated infection, sacrificed
3 days after the end of dexamethasone treatment, showing interstitial
inflammatory cell infiltrates comprising predominantly mononuclear
leukocytes (A). Pulmonary parenchyma from mice at the time of primary
infection (B) showing abundant inflammatory infiltrates and focal
vasculitis (arrows). Hematoxylin and eosin stain, original magnifications
6200.
doi:10.1371/journal.pone.0008547.g001
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immunohistochemical methods. No histopathologic lesions were
identified in the spleens, brains, or livers of any mouse with
dexamethasone-reactivated infection.
R. prowazekii Infection in Cultured Murine Adipocytes
and Demonstration of Rickettsial Persistence in Mouse
Adipose Tissues
By using fluorescence microscopy, R. prowazekii rickettsiae were
identified in the cytoplasms of differentiated adipocytes cell line
3T3-L1 within 1 hour after exposure to cell-free rickettsiae.
Rickettsiae were able to survive and multiply within the murine
adipocyte cell line. At 2 days post-infection, approximately 60%–
70% of 3T3-L1 cells contained 5–10 rickettsiae, and after 4 days,
.90% of the cells contained 10–20 rickettsiae (Figure 2). The
persistence of R. prowazekii in adipose tissues of mice was assessed
by using qPCR, immunostains, and cell culture. Rickettsial DNA
was detected in adipose tissues from both of 2 mice sampled at 20
days and at 97 days pi, and from 6 of 11 mice sampled at 120 days
pi, while no bacterial DNA was detected in any of the other tissues
tested. R. prowazekii was also detected by immunofluorescence and
immunohistochemistry in sections of fixed adipose tissue from 3 of
6 mice sampled at 120 days pi (Figures 3A, B). Viable R. prowazekii
rickettsiae were recovered from peritoneal adipose tissues of 3 of 6
PCR-positive mice sacrificed 4 months after the primary infection.
Indeed, when L929 cells were inoculated with homogenized
peritoneum samples, rickettsiae were detected by Gimenez and
immunofluorescent stains in these cultures weeks later (Figures 3C,
D). Taken together, our data suggest that adipose tissues may
constitute a reservoir for dormant R. prowazekii.
Discussion
Using a recently described murine model for infection with R.
prowazekii [24], we induced a transient rickettsemia .3 months
after the primary infection by long-term treatment with dexa-
methasone. This reactivation was accompanied by a robust and
specific IgG antibody response, without detectable IgM antibodies,
similar to the humoral response associated with Brill-Zinsser
disease [16,17,19,20], and pulmonary lesions similar to, but
generally less extensive than the lesions observed in the lungs of
mice following primary infection with R. prowazekii [24]. In
addition, we were able to detect molecularly and isolate in culture
R. prowazekii from adipose tissues of mice 4 months following
recovery from the primary infection, when no rickettsiae could be
detected in lungs, livers, spleens, or brains of these same mice.
Collectively these results indicate that adipose tissue serves as a
reservoir for recrudescent disease caused by dormant infection
with R. prowazekii, and suggest that adipocytes are the specific cell
type in which dormant rickettsiae reside.
Interestingly, therapy with doxycycline during the primary
infection significantly diminished the frequency of rickettsemia in
mice following treatment with dexamethasone. If an average
bloodmeal consumed by a louse is 0.63 mL [25], it can be
estimated, by using data from our study, that approximately 0–15
copies of R. prowazekii DNA would be ingested by a louse in each
bloodmeal obtained from a doxycycline- treated mouse following
reactivation. In contrast, a louse would ingest approximately 46
DNA copies from the blood of mouse that had recovered from the
primary infection without treatment with doxycycline. These
results suggest that appropriate antibiotic treatment of patients
during outbreaks of epidemic typhus will reduce, but may not
eliminate, the occurrence of recrudescent disease.
The effect of dexamethasone treatment was specific. Indeed, in
our experimental conditions, cyclosporine induced a level of
immune suppression (as measured by IFN-c levels) similar to that
induced by dexamethasone; however, cyclosporine was unable to
reactivate R. prowazekii infection. As cyclosporine acts specifically
on T-cell immune responses, it is unlikely that compromise of
adaptive immunity by itself is sufficient to initiate Brill-Zinsser
disease. In this context, it is possible that dexamethasone initiates
recrudescent infection by anti-inflammatory effects on the host’s
innate immune response [26].
However, it is also possible that long-term treatment with
dexamethasone induces biochemical perturbations in adipose
tissue that are similar to those triggered by one or more of the
exogenous cues that initiate Brill-Zinsser disease, including
starvation and extreme social stress. Secretion of endogenous
glucocorticoids is increased significantly in starved animals [27],
Figure 2. Intracellular replication of R. prowazekii in 3T3-L1
adipocytes. Adipocytes were infected with R. prowazekii (bacterium-
to-cell ratio of 50:1) for 1 hour, washed and cultured for 2 and 4 days.
Infection was measured by immunofluorescence. Results represent
mean values (6SD) of 3 experiments.
doi:10.1371/journal.pone.0008547.g002
Figure 3. Immunodetection and isolation of R. prowazekii from
adipose tissues 4 months after primary infection. Immunofluo-
rescence staining showing R. prowazekii rickettsiae in adipocytes
(arrows), using an anti-OmpB monoclonal antibody (A), and rare
staining (red-brown) using an immunoperoxidase technique with a
polyclonal anti-R. prowazekii antibody (B). Gimenez (C), and immuno-
fluorescence (D)-stained preparations of intracellular R. prowazekii
rickettsiae, isolated from murine adipose tissues in L929 cells. Original
magnifications 6400.
doi:10.1371/journal.pone.0008547.g003
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dexamethasone to animals causes a diminution of fat depots that
resemble closely the effects of chronic starvation [28]. More
recently, investigators have shown that dexamethasone down-
regulates the expression of lipoprotein lipase in vitro and in vivo
[29]. Adipocytes obtain most of the lipid needed for triglyceride
synthesis by the activity of lipoprotein lipase; dexamethasone
alters directly the physiology of these cells and decreases
intracellular triglycerides in a manner similar to prolonged caloric
restriction. Because dexamethasone also acts on lipid metabolism
via the lipoxygenase pathway [30], it is possible that glucocorti-
coids affect adipocyte physiology through several biochemical
pathways.
The physiologic complexity of adipose tissue extends far beyond
its role as a depot for triglycerides. Indeed, adipocytes are
metabolically active endocrine cells that play a crucial role in
energy homeostasis, and provide important immunologic functions
[31]. The biochemistry of these cells may be modulated by other
hormones, cytokines, and macromolecules, and it is possible that
the pathogenesis of rickettsial reactivation from adipose tissue
depends on multiple and varied physiological stimuli. By example,
tumor necrosis factor-a potentiates the reduction of intracellular
lipids in starved adipocytes [32]; interestingly, mice exposed to
conditions of social disruption and stress secrete markedly elevated
levels of TNF-a [33].
Adipose tissue includes a minority of cell types other than
adipocytes, including fibroblasts, macrophages, pericytes, vascular
endothelium, and smooth muscle cells [31]. We cannot say
definitively that adipocytes are the specific cell that sequesters
dormant R. prowazekii rickettsiae; however, some or all of these
non-adipocyte cells are plentiful in each of the other non-adipose
tissues from which no rickettsiae were detected molecularly or
isolated in culture months after the primary infection. In this
context, we believe that the adipocyte constitutes the principal
cellular reservoir for dormant typhus infection in our mouse
model. The precise cellular location of dormant R. prowazekii
rickettsiae in infected human hosts remains unknown. To our
knowledge, culture isolation of dormant R. prowazekii rickettsiae
from humans has been described by only once [13], from inguinal
lymph node tissues from 2 of 16 Russian immigrants undergoing
abdominal surgery in the United States, presumably many years
after the primary infection. Because some adipose tissue often
accompanies lymph node specimens excised during surgical
procedures, it is possible that adipose tissue, rather than the
lymph nodes, provided the source for recovery of rickettsiae.
Isolation from humans of other types of rickettsiae, including
Rickettsia rickettsii (the agent of Rocky Mountain spotted fever) and
Orientia tsutsugamushi (the agent of scrub typhus), as long as 1 year
after clinical recovery, has been reported rarely [21,34]. Coxiella
burnetii, the causative agent of Q fever, also persists for long time in
mice and the persisting bacteria can be transmitted at least to 2
generations [35].
The evaluation of additional tissues from infected mice,
including lymph nodes , bone marrow, or other viscera, may
yield other locations with dormant R. prowazekii rickettsiae;
however, it is likely that adipocytes play a crucial, and perhaps
unique role in Brill-Zinsser disease. Adipocytes are know
recognized as important reservoirs of other intracellular pathogens
that remain dormant for many years after the primary infection,
including Trypanosoma cruzi [36], Mycobacterium tuberculosis [37], and
Coxiella burnetii (Y. Bechah, unpub. data). A careful inspection of
the complex biochemical interactions between adipocytes and
various metabolic and immunologic pathways are needed to better
characterize the pathogenesis of Brill-Zinsser disease; indeed, the
propagation of M. tuberculosis in adipocytes depends on lipid
metabolism [38].
Pulmonary inflammation was identified only in the lungs of
mice with dexamethasone-reactivated R. prowazekii infection. In a
previous study [24] we demonstrated abundant rickettsial antigens
in the lungs of mice following primary infection with R. prowazekii.
In this investigation, we failed to detect antigens by immunohis-
tochemical methods in the lungs of mice with dexamethsone-
reactivated infections; however, pulmonary rickettsial loads
following primary disease determined in our earlier study were
approximately 5 times greater than the levels detected in the lungs
of mice with recrudescent disease. Dexamethasone is known to
reduce the basal expression and the production of tracheal
antimicrobial peptides (defensins) [39] and enhance the suscepti-
bility to respiratory diseases [40]. This may influence the
appearance of inflammatory reactions in lungs by decreasing their
antimicrobial activity or interfering with their ability to recruit and
activate inflammatory cells.
In conclusion, we describe for the first time a recrudescent form
of epidemic typhus in a murine model. In this model adipose tissue
represents a reservoir in which bacteria may avoid killing by drugs
and host defense mechanisms. This model can be applied to test
new therapeutic strategies that eradicate dormant bacteria and
prevent the occurrence Brill-Zinsser disease, and provide new
insights in the pathogenesis of this disease and the mechanisms
that allow R. prowazekii to persist in vertebrate hosts.
Materials and Methods
Ethics Statement
The mice used in our study were handled according to the rules
of De ´cret Nu 87–848 du 19/10/1987, Paris. The experimental
protocol have been reviewed and approved by the Institutional
Animal Care and Use Committee of the Universite ´d el a
Me ´diterrane ´e.
Bacterial Preparation
R. prowazekii strain Breinl (ATCC VR-142) was propagated as
recently described [24]. Monolayers of murine L929 cells were
infected for 7 days and bacteria were harvested and quantified as
previously described [41]. The identity of R. prowazekii was
confirmed by sequencing of PCR products using gltA primers, as
previously described [42]. Heat-inactivated R. prowazekii rickettsiae
were obtained by a 60uC treatment for 30 min.
Experimental Design
7 week-old female BALB/c mice were obtained from Charles
River Laboratories. Mice were housed in a biosafety level 3
laboratory and provided sterile food and water ad libitum. Mice
were infected with a single dose of 1610
5 bacteria injected
intravenously (iv) into the retro-orbital plexus [24]. In the first set
of experiments, R. prowazekii-infected mice were separated into 4
experimental groups (Figure 4). Whole blood specimens were
collected by retro-orbital puncture at 3, 6, 9, 30, 60 pi from mice
in each group and stored at 220uC for PCR experiments and
serum antibody determination (see below). One week post
infection, mice from group 1 (n=6) received a dose of
doxycycline (10 mg/kg body weight) per os on days 7 and 9.
At 60 days pi, the mice from group 1, and 8 infected but non-
treated mice, comprising group 2, were given dexamethasone
(160 mgi n2 0 0mL PBS) daily for 30 days by intraperitoneal (ip)
injection. Another 8 infected but non-treated mice, comprising
group 3, were given cyclosporine (40 mg/kg of body weight) daily
for 20 days by ip injection. Six infected but non-treated mice,
R. prowazekii Reactivation
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daily for 20 days by ip injection as sham immunosuppression.
Mice were sacrificed at days 3 (n=5) and 8 (n=3) after the
completion of each immuosuppresive treatment. Representative
samples of liver, lungs, spleen, and brain were excised aseptically
and frozen at 280uC for subsequent PCR assays and cell culture
isolation. Samples from each organ were also fixed in 10%
formalin for histological and immunohistochemical evaluation.
In a second set of experiments, infected mice were assessed for
persistence of R. prowazekii at days 20, 97, and 120 pi.
Representative samples of liver, lungs, spleen, brain, white adipose
tissue from the peritoneum, subcutaneous adipose tissue from the
inguinal region, and brown adipose tissue from the dorsal region
were excised aseptically at necropsy and frozen at 280uC or fixed
in 10% formalin for subsequent PCR assays, inoculation into cell
culture and immunostaining.
IFN-c Release by Splenocytes
Splenocytes were isolated from treated or non- treated mice to
determine the efficiency of immunosuppression. Briefly, spleno-
cytes (2610
6 cells/well) were incubated in RPMI1640, containing
25mM HEPES, 10% FBS, 2 mM L-glutamine, 100 U/ml
penicillin, and 100 mg/ml streptomycin, in the presence or
absence of heat-inactivated R. prowazekii (10 rickettsiae per cell)
for 24 h [24]. Supernatants were stored at 280uC, and interferon
(IFN)-c levels were determined by immunoassay (R&D Systems;
detection limit, 2 pg/mL).
Blood and Tissue Infection
Bacterial infection was studied by qPCR and shell vial isolation.
DNA was extracted from whole blood (200 mL) and tissue samples
(25 mg) using the QIAamp Tissue kit (Qiagen). Negative controls
consisted of DNA extracts from sham-immunosuppressed mice.
DNA was extracted in a final volume of 100 mL. qPCR was
performed on 5 ml of blood or tissue DNA extracts using the
LightCycler system (Roche Diagnostics) targeting a segment of the
rickettsial gltA gene [24]. For isolation, tissue samples were first
triturated in 2 mL of medium using a sterile scalpel blade. Blood
(200 mL) and tissue triturates (500 mL) were inoculated into shell
vials containing confluent monolayer of L929 fibroblasts. Rickett-
sial infection of L929 cells was monitored by using Gimenez
staining [43].
Histopathologic Evaluation and Immunostaining for R.
prowazekii
Formalin-fixed, paraffin-embedded tissues were cut at 4-mm
and stained with hematoxylin and eosin for histopathologic
examination. Sections of peritoneal adipose tissue obtained
from mice 4 months pi were also evaluated by immunohisto-
chemical and immunofluorecsence stains using a polyclonal
rabbit anti-R. prowazekii hyperimmune serum diluted to 1/2000
for immunohistochemistry, or a monoclonal anti-R. prowazekii
OmpB antibody diluted to 1/500 for immunofluorescence
[24].
Figure 4. Experimental protocol for study of Rickettsia prowazekii persistence and reactivation in BALB/c mice. BALB/c mice were
infected intravenously (via the retro-orbital venous plexus) with 1610
5 bacteria. Doxycycline was administered to group 1 (*) per os on days 7 and 9.
Two months following the primary infection, mice were immunosuppressed with dexamethasone or cyclosporine via the intra-peritoneal route. A
control group received sham immunosuppression with phosphate buffered saline. To study bacterial persistence, infected mice were sacrificed at
days 20 (n=2 mice), and 97 (n=2) post-challenge and the presence of bacteria in different organs was assessed by PCR, cell culture, and
immunostaining. Mice sacrificed at 120 days post-infection (n=11) were infected in a separate experiment and bacterial persistence was evaluated by
the same techniques.
doi:10.1371/journal.pone.0008547.g004
R. prowazekii Reactivation
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To determine the titer of circulating antibodies directed against
R. prowazekii, slides prepared with air-dried, methanol-fixed
rickettsiae were incubated with serial dilutions of mouse serum
for 30 min. After washing, the bacteria were revealed using
labeled goat antibodies directed against IgM or IgG (Beckman
Coulter) at a 1:100 dilution for 30 min. The slides were then
washed and examined using a Zeiss fluorescence microscope [24].
Reverse Transcription-PCR (RT-PCR) for b-defensin
RT-PCR for b-defensin was carried out as previously described
[24]. Briefly, total RNA was isolated from lung tissue using a
Qiagen kit. cDNA synthesis was obtained by using an oligo(dT)
primer and M-MLV reverse transcriptase (Invitrogen). PCR was
performed using the cDNA targeting b-defensin 1(Defb1) with the
following primers (forward and reverse): Defb1,5 9-CC-
AGCTGCCCATCTAATACC-39 and 59-AATCCATCGCT-
CGTCCTTTA-39. b-actin used as control, F59-TGGAAT-
CCTGTGGCATCCATGAAA-C-39,R 5 9-TAAAACGC-AGCT-
CAGTAACAGTCCG-39. PCR parameters were: denaturation at
94uC for 3 min, followed by 45 cycles of 94uC for 30 s, annealing
at 54uC and final extension at 72uC for 1 min. The fold change
(FC) in expression of Defb1 relative to b-actin was determined
as follows: FC=2
2DDCt where DDCt=(CtTarget2CtActin)sample2
(CtTarget2CtActin)reference, with the sample values represented by
tissues from dexamethasone-treated mice and the reference values
as tissues from non-treated mice.
In Vitro Propagation of R. prowazekii in Cultured Murine
Adipocytes
Adipocytes were prepared as previously described [37]. Briefly,
murine 3T3-L1 fibroblasts (ATCC, Manassas, VA) were seeded
on 12-mm diameter glass coverslips in 24 well-plates at 4610
4
cells/well, and incubated in Dulbecco’s modified Eagle’s medium
(DMEM) (Invitrogen) containing 10% FCS and 2 mM L-
glutamine. When cells were confluent, adipocyte differentiation
was induced by adding 100 mM 3-isobutyl-1-methylxanthine
(IBMX), 250 nM dexamethasone and 1 mg bovine insulin. After
2 days, the medium was replaced with DMEM containing 10%
FCS and 1 mg insulin. Differentiated adipocytes were infected with
rickettsiae after an additional 3 days. Uptake of R. prowazekii by
adipocytes and the intracellular fate of rickettsiae were studied as
follows. Cells were incubated with R. prowazekii (50 rickettsiae per
cell) for 1 h at 37uC and unbound bacteria were removed by
extensive washing. Cells were then incubated with DMEM
containing 10% FCS and L-glutamine. Bacterial replication in
differentiated 3T3-L1 cells over time was determined over time by
immunofluorescence staining. Cell cultures were fixed on glass
slides in 3% paraformaldehyde, permeabilized with 0.1% Triton
X-100, and stained by using a monoclonal anti-R. prowazekii
OmpB antibody diluted at 1/500. Stained slides were mounted
with Mowiol and the cells were examined using epifluorescence
microscopy. The percentage of infection was calculated as 1006
the product of the mean number of rickettsiae per infected cell and
the percentage of infected cells.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism,
software 4.0. Quantitative data were compared with the Mann-
Whitney U test or Fisher test. P values,0.05 were considered
significant.
The findings and conclusions described herein are those of the
authors and do not necessarily represent the views of the U.S.
Department of Health and Human Services.
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